Bank of New York Mellon’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,326
| Closed | -$74K | – | 4606 |
|
|
2022
Q1 | $74K | Sell |
3,326
-14
| -0.4% | -$311 | ﹤0.01% | 4459 |
|
|
2021
Q4 | $114K | Hold |
3,340
| – | – | ﹤0.01% | 4385 |
|
|
2021
Q3 | $205K | Hold |
3,340
| – | – | ﹤0.01% | 4201 |
|
|
2021
Q2 | $260K | Sell |
3,340
-1,561
| -32% | -$122K | ﹤0.01% | 4005 |
|
|
2021
Q1 | $273K | Sell |
4,901
-102
| -2% | -$5.68K | ﹤0.01% | 3945 |
|
|
2020
Q4 | $306K | Buy |
5,003
+583
| +13% | +$35.7K | ﹤0.01% | 3823 |
|
|
2020
Q3 | $538K | Sell |
4,420
-28
| -0.6% | -$3.41K | ﹤0.01% | 3455 |
|
|
2020
Q2 | $526K | Sell |
4,448
-360
| -7% | -$42.6K | ﹤0.01% | 3442 |
|
|
2020
Q1 | $255K | Sell |
4,808
-9
| -0.2% | -$477 | ﹤0.01% | 3663 |
|
|
2019
Q4 | $262K | Buy |
4,817
+537
| +13% | +$29.2K | ﹤0.01% | 3836 |
|
|
2019
Q3 | $1.04M | Buy |
4,280
+395
| +10% | +$95.8K | ﹤0.01% | 3161 |
|
|
2019
Q2 | $890K | Buy |
+3,885
| New | +$890K | ﹤0.01% | 3294 |
|